Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pcositol is a multi-ingredient nutritional supplement (nutraceutical) developed and distributed by Delfran Pharmaceuticals, specifically formulated to support women with Polycystic Ovary Syndrome (PCOS) and enhance female reproductive health. The product features a clinically recognized 40:1 ratio of Myo-inositol to D-chiro-inositol, which works to improve insulin sensitivity, restore hormonal balance, and promote regular ovulation. In addition to inositols, Pcositol contains a comprehensive blend of 11 essential nutrients, including Co-enzyme Q10 for antioxidant support, Folate (as L-5-methyltetrahydrofolate) for metabolic health, and various vitamins and minerals (Magnesium, Chromium, Zinc, Calcium, Vitamin B12, D3, and K2) to improve metabolic parameters and oocyte quality in women undergoing fertility treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pcositol.